{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Angiogenesis", "Developmental toxicity", "Phytochemical screening", "Rumex vasicarius L.", "Zebrafish embryos"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32210679", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "12", "Day": "06"}], "Language": ["eng"], "ELocationID": ["10.1016/j.sjbs.2019.11.042"], "Journal": {"ISSN": "1319-562X", "JournalIssue": {"Volume": "27", "Issue": "2", "PubDate": {"Year": "2020", "Month": "Feb"}}, "Title": "Saudi journal of biological sciences", "ISOAbbreviation": "Saudi J Biol Sci"}, "ArticleTitle": "Investigating the antiangiogenic potential of <i>Rumex vesicarius</i> (humeidh), anticancer activity in cancer cell lines and assessment of developmental toxicity in zebrafish embryos.", "Pagination": {"StartPage": "611", "EndPage": "622", "MedlinePgn": "611-622"}, "Abstract": {"AbstractText": ["Recent trends in anticancer therapy is to use therapeutic agents which not only kill the cancer cell, but are less toxic to surrounding normal cells/tissue. One approach is to cut the nutrient supply to growing tumor cells, by blocking the formation of new blood vessels around the tumor. As the phytochemicals and botanical crude extracts have proven their efficacy as natural antiangiogenic agents with minimum toxicities, there is need to explore varieties of medicinal plants for novel antiangiogenic compounds. <i>Rumex vesicarius L.</i> (Humeidh), is an annual herbal plant with proven medicinal values. The antiangiogenic potential, and developmental toxicity of humeidh in experimental animal models has never been studied before. The crude extracts were prepared from the roots, stems, leaves and flowers of <i>Rumex vesicarius L.</i> in methanol, chloroform, ethyl acetate and n-hexane. The developmental toxicity screening in zebrafish embryos, has revealed that <i>Rumex vesicarius</i> was not toxic to zebrafish embryos<i>.</i> The chloroform stem extract showed significant level of antiangiogenic activity in zebrafish angiogenic assay on a dose dependent manner. Thirty five (35) bioactive compounds were identified by gas chromatography mass spectrophotometry (GC-MS) analysis in the stem extract of <i>Rumex vesicarius</i>. Propanoic acid, 2-[(trimethylsilyl)oxy]-, trimethylsilyl ester, Butane, 1,2,3-tris(trimethylsiloxy), and Butanedioic acid, bis(trimethylsilyl) ester were identified as major compound present in the stem of <i>R. vasicarius</i>. The anticancer activity of roots, stem, leaves and flowers crude extract was evaluated in human breast cancer (MCF7), human colon carcinoma (Lovo, and Caco-2), human hepatocellular carcinoma (HepG2) cell lines. Most of the crude extracts did not show significant level of cytotoxicity in tested cancer cells line, except, chloroform extract of stem which exhibited strong anticancer activity in all tested cancer cells with IC<sub>50</sub> values in micro molar range. Based on these results, it is recommended that formulation prepared from <i>R. vesicarius</i> can further be tested in clinical trials in order to explore its therapeutic potential as an effective and safe natural anticancer product."], "CopyrightInformation": "\u00a9 2019 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia."}], "LastName": "Farooq", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia."}], "LastName": "Abutaha", "ForeName": "Nael", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, College of Science, King Saud University, 11451 Riyadh, Saudi Arabia."}], "LastName": "Mahboob", "ForeName": "Shahid", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia."}], "LastName": "Baabbad", "ForeName": "Almohannad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia."}], "LastName": "Almoutiri", "ForeName": "Nawaf D", "Initials": "ND"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia."}], "LastName": "Wadaan", "ForeName": "Mohammad Ahmed A M", "Initials": "MAAM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Saudi Arabia", "MedlineTA": "Saudi J Biol Sci", "NlmUniqueID": "101543796", "ISSNLinking": "2213-7106"}, "CoiStatement": "No conflict of interest to be declared."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abdel-Qadir H., Ethier J.L., Lee D.S., Thavendiranathan P., Amir E. Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: a systematic review and meta-analysis. Cancer Treat Rev. 2017:53120\u201353127.", "ArticleIdList": ["28104567"]}, {"Citation": "Al-Abd A.M., Alamoudi A.J., Abdel-Naim A.B., Neamatallah T.A., Ashour O.M. Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies \u2013 a review. J. Adv. Res. 2017;8(6):591\u2013605.", "ArticleIdList": ["PMC5544473", "28808589"]}, {"Citation": "Arbiser J.L., Klauber N., Rohan R., van Leeuwen R., Huang M.T., Fisher C., Flynn E., Byers H.R. Curcumin is an in vivo inhibitor of angiogenesis. Mol. Med. 1998;4(6):376\u2013383.", "ArticleIdList": ["PMC2230271", "10780880"]}, {"Citation": "Boulton M.E., Cai J., Grant M.B. Gamma-secretase: a multifaceted regulator of angiogenesis. J. Cell Mol. Med. 2008;12(3):781\u2013795.", "ArticleIdList": ["PMC4401127", "18266961"]}, {"Citation": "Butler C.T., Reynolds A.L., Tosetto M., Dillon E.T., Guiry P.J., Cagney G., O'Sullivan J., Kennedy B.N. A quininib analogue and cysteinyl leukotriene receptor antagonist inhibits vascular endothelial growth factor (VEGF)-independent angiogenesis and exerts an additive antiangiogenic response with bevacizumab. J. Biol. Chem. 2017;292(9):3552\u20133567.", "ArticleIdList": ["PMC5339742", "28035003"]}, {"Citation": "Cao Y. Future options of anti-angiogenic cancer therapy. Chin. J. Cancer. 2016;3521", "ArticleIdList": ["PMC4753668", "26879126"]}, {"Citation": "Cao Y., Fu Z.D., Wang F., Liu H.Y., Han R. Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J. Asian Nat. Prod. Res. 2005;7(3):205\u2013213.", "ArticleIdList": ["15621628"]}, {"Citation": "Chen Z., Tong L.J., Tang B.Y., Liu H.Y., Wang X., Zhang T., Cao X.W., Chen Y., Li H.L., Qian X.H., Xu Y.F., Xie H., Ding J. C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis. Acta Pharmacol. Sin. 2019;40(6):823\u2013832.", "ArticleIdList": ["PMC6786402", "30487650"]}, {"Citation": "Clark A.N., Youkey R., Liu X., Jia L., Blatt R., Day Y.J., Sullivan G.W., Linden J., Tucker A.L. A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ. Res. 2007;101(11):1130\u20131138.", "ArticleIdList": ["17901362"]}, {"Citation": "Cooke J.P., Ghebremariam Y.T. Endothelial nicotinic acetylcholine receptors and angiogenesis. Trends Cardiovasc. Med. 2008;18(7):247\u2013253.", "ArticleIdList": ["PMC2673464", "19232953"]}, {"Citation": "Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., Ng C.S., Badmaev V., Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008;14(14):4491\u20134499.", "ArticleIdList": ["18628464"]}, {"Citation": "Erices J.I., Torres A., Niechi I., Bernales I., Quezada C. Current natural therapies in the treatment against glioblastoma. Phytother. Res. 2018;32(11):2191\u20132201.", "ArticleIdList": ["30109743"]}, {"Citation": "Farooq M., Al Marhoon Z.M., Abu Taha N., Baabbad A.A., Al-Wadaan M.A., El-Faham A. Synthesis of novel class of N-alkyl-isatin-3-iminobenzoic acid derivatives and their biological activity in zebrafish embryos and human cancer cell lines. Biol. Pharm. Bull. 2018;41(3):350\u2013359.", "ArticleIdList": ["29249771"]}, {"Citation": "Farooq M., Sharma A., Almarhoon Z., Al-Dhfyan A., El-Faham A., Taha N.A., Wadaan M.A.M., Torre B.G., Albericio F. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos. Bioorg. Chem. 2019:87457\u201387464.", "ArticleIdList": ["30927586"]}, {"Citation": "Fong T.A., Shawver L.K., Sun L., Tang C., App H., Powell T.J., Kim Y.H., Schreck R., Wang X., Risau W., Ullrich A., Hirth K.P., McMahon G. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 1999;59(1):99\u2013106.", "ArticleIdList": ["9892193"]}, {"Citation": "Ganaie M.A., Khan T.H., Siddiqui N.A., Ansari M.N. Ameliorative effect of methanol extract of Rumex vesicarius on CCl4-induced liver damage in Wistar albino rats. Pharm. Biol. 2015;53(8):1163\u20131167.", "ArticleIdList": ["25702903"]}, {"Citation": "Gezici S., Sekeroglu N. Current perspectives in the application of medicinal plants against cancer: novel therapeutic agents. Anticancer Agents Med. Chem. 2019;19(1):101\u2013111.", "ArticleIdList": ["30582485"]}, {"Citation": "Gfeller D., Michielin O., Zoete V. Shaping the interaction landscape of bioactive molecules. Bioinformatics. 2013;29(23):3073\u20133079.", "ArticleIdList": ["24048355"]}, {"Citation": "Harley R.M. Flora of Eastern Saudi-Arabia \u2013 Mandaville, Jp. Tls-Times Lit. 1991 Suppl (4598) 20\u201320."}, {"Citation": "Harmsma M., Gromme M., Ummelen M., Dignef W., Tusenius K.J., Ramaekers F.C. Differential effects of Viscum album extract IscadorQu on cell cycle progression and apoptosis in cancer cells. Int. J. Oncol. 2004;25(6):1521\u20131529.", "ArticleIdList": ["15547686"]}, {"Citation": "Haspel H.C., Scicli G.M., McMahon G., Scicli A.G. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Microvasc. Res. 2002;63(3):304\u2013315.", "ArticleIdList": ["11969307"]}, {"Citation": "Ishikawa H., Saeki T., Otani T., Suzuki T., Shimozuma K., Nishino H., Fukuda S., Morimoto K. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J. Nutr. 2006;136(3 Suppl):816S\u2013820S.", "ArticleIdList": ["16484572"]}, {"Citation": "Manure J.Y., Naikwade N.S. Evaluation of anticancer activity of leaves of Rumex vesicarius Linn and Symplocos racemosa Roxb. by brine shrimp lethality and (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) methods. Int. J. Green Pharm. 2017;11:(4)|S742."}, {"Citation": "Kalen M., Wallgard E., Asker N., Nasevicius A., Athley E., Billgren E., Larson J.D., Wadman S.A., Norseng E., Clark K.J., He L., Karlsson-Lindahl L., Hager A.K., Weber H., Augustin H., Samuelsson T., Kemmet C.K., Utesch C.M., Essner J.J., Hackett P.B., Hellstrom M. Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets. Chem. Biol. 2009;16(4):432\u2013441.", "ArticleIdList": ["PMC3984492", "19389629"]}, {"Citation": "Khalid, El Bairi, Meghawry E.L., Kenawy Ayman E.L., Rahman Heshu, Abdelkarim Guaadaoui, Najda Agnieszka. Natural products against cancer angiogenesis. Tumor Biol. 2016;37(11):14513\u201314536.", "ArticleIdList": ["27651162"]}, {"Citation": "Kuete V., Wiench B., Alsaid M.S., Alyahya M.A., Fankam A.G., Shahat A.A., Efferth T. Cytotoxicity, mode of action and antibacterial activities of selected Saudi Arabian medicinal plants. BMC Complement Altern. Med. 2013 13354.", "ArticleIdList": ["PMC4029389", "24330397"]}, {"Citation": "Lawson N.D., Weinstein B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 2002;248(2):307\u2013318.", "ArticleIdList": ["12167406"]}, {"Citation": "Liu J.J., Huang T.S., Cheng W.F., Lu F.J. Baicalein and baicalin are potent inhibitors of angiogenesis: inhibition of endothelial cell proliferation, migration and differentiation. Int. J. Cancer. 2003;106(4):559\u2013565.", "ArticleIdList": ["12845652"]}, {"Citation": "Lu V.M., Ravindran K., Graffeo C.S., Perry A., Van Gompel J.J., Daniels D.J., Link M.J. Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes. J. Neurooncol. 2019;144(2):239\u2013248.", "ArticleIdList": ["31254266"]}, {"Citation": "Medina M.A., Munoz-Chapuli R., Quesada A.R. Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope. J. Cell Mol. Med. 2007;11(3):374\u2013382.", "ArticleIdList": ["PMC3922346", "17635633"]}, {"Citation": "Mendel D.B., Schreck R.E., West D.C., Li G., Strawn L.M., Tanciongco S.S., Vasile S., Shawver L.K., Cherrington J.M. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function. Clin. Cancer Res. 2000;6(12):4848\u20134858.", "ArticleIdList": ["11156244"]}, {"Citation": "Miettinen M., Rikala M.S., Rys J., Lasota J., Wang Z.F. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors. Am. J. Surg. Pathol. 2012;36(4):629\u2013639.", "ArticleIdList": ["PMC3310951", "22314185"]}, {"Citation": "Nasr Fa.hd.A., Abutaha Nael, Al-Zahrani Mohammad, Farooq Muhammad, Wadaan Mohammad A. Anticancer potential of plant extracts from riyadh (Saudi Arabia) on Mda-Mb-231 breast cancer cells. Afr. J. Traditional, Complem. Alternat. Med. 2018;15(4):46\u201353."}, {"Citation": "Qin S., Li A., Yi M., Yu S., Zhang M., Wu K. Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy. J. Hematol. Oncol. 2019;12(1):27.", "ArticleIdList": ["PMC6417086", "30866992"]}, {"Citation": "R.H.D, undefined 1952. Probit Analysis. By D. J. Finney, M.A., Sc.D., [2nd ed. Pp. xiv + 318. Cambridge University Press, 1952. 35s.]. J. Inst. Actuaries 78(3), pp. 388\u2013390."}, {"Citation": "Raghunath M., Wong Y.S., Farooq M., Ge R. Pharmacologically induced angiogenesis in transgenic zebrafish. Biochem. Biophys. Res. Co. 2009;378(4):766\u2013771.", "ArticleIdList": ["19068208"]}, {"Citation": "Rahman M.A., Mossa J.S., Al-Said M.S., Al-Yahya M.A. Medicinal plant diversity in the flora of Saudi Arabia 1: a report on seven plant families. Fitoterapia. 2004;75(2):149\u2013161.", "ArticleIdList": ["15030919"]}, {"Citation": "Song M., Finley S.D. Mechanistic insight into activation of MAPK signaling by pro-angiogenic factors. BMC Syst. Biol. 2018;12(1):145.", "ArticleIdList": ["PMC6307205", "30591051"]}, {"Citation": "Song Y., Wang H., Pan Y., Liu T. Investigating the multi-target pharmacological mechanism of hedyotis diffusa willd acting on prostate cancer: a network pharmacology approach. Biomolecules. 2019;9(10)", "ArticleIdList": ["PMC6843553", "31600936"]}, {"Citation": "Subramaniyan V., Shaik S., Bag A., Manavalan G., Chandiran S. Potential action of Rumex vesicarius (L.) against potassium dichromate and gentamicin induced nephrotoxicity in experimental rats. Pak. J. Pharm. Sci. 2018;31(2):509\u2013516.", "ArticleIdList": ["29618442"]}, {"Citation": "Vasas A., Orban-Gyapai O., Hohmann J. The genus rumex: review of traditional uses, phytochemistry and pharmacology. J. Ethnopharmacol. 2015:175198\u2013175228.", "ArticleIdList": ["26384001"]}, {"Citation": "Viallard C., Larrivee B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409\u2013426.", "ArticleIdList": ["28660302"]}, {"Citation": "Wang Zongwei, Dabrosin Charlotta, Yin Xin, Fuster Mark M., Alexandra Arreola W., Rathmell Kimryn, Generali Daniele, Nagaraju Ganji P., El-Rayes Bassel, Ribatti Domenico, Chen Yi Charlie, Honoki Kanya, Fujii Hiromasa, Georgakilas Alexandros G., Nowsheen Somaira, Amedei Amedeo, Niccolai Elena, Amr Amin S., Ashraf Salman, Helferich Bill, Yang Xujuan, Guha Gunjan, Bhakta Dipita, Ciriolo Maria Rosa, Aquilano Katia, Chen Sophie, Halicka Dorota, Mohammed Sulma I., Azmi Asfar S., Alan Bilsland W., Keith Nicol, Jensen Lasse D. Broad targeting of angiogenesis for cancer prevention and therapy. Seminars Cancer Biol. 2015;35:S224\u2013S243.", "ArticleIdList": ["PMC4737670", "25600295"]}, {"Citation": "Wilhelm S.M., Carter C., Tang L., Wilkie D., McNabola A., Rong H., Chen C., Zhang X., Vincent P., McHugh M., Cao Y., Shujath J., Gawlak S., Eveleigh D., Rowley B., Liu L., Adnane L., Lynch M., Auclair D., Taylor I., Gedrich R., Voznesensky A., Riedl B., Post L.E., Bollag G., Trail P.A. BAY 43\u20139006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 2004;64(19):7099\u20137109.", "ArticleIdList": ["15466206"]}, {"Citation": "Yakkundi A., Bennett R., Hernandez-Negrete I., Delalande J.M., Hanna M., Lyubomska O., Arthur K., Short A., McKeen H., Nelson L., McCrudden C.M., McNally R., McClements L., McCarthy H.O., Burns A.J., Bicknell R., Kissenpfennig A., Robson T. FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis. Arterioscler Thromb Vasc. Biol. 2015;35(4):845\u2013854.", "ArticleIdList": ["PMC4415967", "25767277"]}, {"Citation": "Zhu B., Zhang L., Alexeyev M., Alvarez D.F., Strada S.J., Stevens T. Type 5 phosphodiesterase expression is a critical determinant of the endothelial cell angiogenic phenotype. Am. J. Physiol. Lung Cell Mol. Physiol. 2009;296(2):L220\u2013L228.", "ArticleIdList": ["PMC2643995", "19028977"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "4"}, {"Year": "2019", "Month": "11", "Day": "26"}, {"Year": "2019", "Month": "11", "Day": "28"}, {"Year": "2020", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "27", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "12", "Day": "6"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32210679", "PMC6997907", "10.1016/j.sjbs.2019.11.042", "S1319-562X(19)30276-1"]}}]}